Alan D. Watson
Corporate Officer/Principal chez Targeted Diagnostics & Therapeutics, Inc.
Profil
Dr. Alan D.
Watson is a Director at IMCOR Pharmaceutical Co., Vice President-Business Development at SmartCells, Inc., and Entrepreneur-in-Residence at Oxford Bioscience Partners.
He is on the Board of Directors at IMCOR Pharmaceutical Co. and Targeted Diagnostics & Therapeutics, Inc.
Dr. Watson was previously employed as Senior Vice President-Corporate Development by Cubist Pharmaceuticals, Inc.
He received his undergraduate degree from The University of New South Wales, an MBA from Northeastern University, and a doctorate degree from Australian National University.
Postes actifs de Alan D. Watson
| Sociétés | Poste | Début |
|---|---|---|
Targeted Diagnostics & Therapeutics, Inc.
 Targeted Diagnostics & Therapeutics, Inc. Medical SpecialtiesHealth Technology Targeted Diagnostics & Therapeutics, Inc. operates as a biotechnology company. The firm develops molecular diagnostics and therapeutics for the diagnosis and treatment of colorectal cancer and other gastrointestinal diseases. Its activities include research and development projects in in-vitro diagnostics and imaging agents, receptor-based therapeutics, and cancer vaccines; and a clinical laboratory for testing blood and tissues for metastatic colorectal cancer for patients. The company was founded by Harry A. Arena in August 1994 and is headquartered in West Chester, PA. | Corporate Officer/Principal | - |
Anciens postes connus de Alan D. Watson
| Sociétés | Poste | Fin |
|---|---|---|
Oxford Bioscience Partners
 Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston. | Corporate Officer/Principal | - |
| CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | - |
SmartCells, Inc.
 SmartCells, Inc. Medical SpecialtiesHealth Technology SmartCells, Inc. develops glucose-regulated smart insulin products for the treatment of diabetes. The company was founded by Todd C. Zion and James M. Herriman in 2003 and is headquartered in Beverly, MA. | Corporate Officer/Principal | - |
IMCOR Pharmaceutical Co.
 IMCOR Pharmaceutical Co. Medical SpecialtiesHealth Technology IMCOR Pharmaceutical Co. is a development-stage pharmaceutical company focused on developing medical imaging pharmaceutical products. Currently, the company's core business focus has evolved from an operating entity conducting research and development, manufacturing and limited selling activities. The company was founded by H. Craig Dees and Eric A. Wachter on December 28, 1994 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Formation de Alan D. Watson
| Australian National University | Doctorate Degree |
| Northeastern University | Masters Business Admin |
| The University of New South Wales | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Oxford Bioscience Partners
Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston. | Finance |
IMCOR Pharmaceutical Co.
IMCOR Pharmaceutical Co. Medical SpecialtiesHealth Technology IMCOR Pharmaceutical Co. is a development-stage pharmaceutical company focused on developing medical imaging pharmaceutical products. Currently, the company's core business focus has evolved from an operating entity conducting research and development, manufacturing and limited selling activities. The company was founded by H. Craig Dees and Eric A. Wachter on December 28, 1994 and is headquartered in San Diego, CA. | Health Technology |
Targeted Diagnostics & Therapeutics, Inc.
Targeted Diagnostics & Therapeutics, Inc. Medical SpecialtiesHealth Technology Targeted Diagnostics & Therapeutics, Inc. operates as a biotechnology company. The firm develops molecular diagnostics and therapeutics for the diagnosis and treatment of colorectal cancer and other gastrointestinal diseases. Its activities include research and development projects in in-vitro diagnostics and imaging agents, receptor-based therapeutics, and cancer vaccines; and a clinical laboratory for testing blood and tissues for metastatic colorectal cancer for patients. The company was founded by Harry A. Arena in August 1994 and is headquartered in West Chester, PA. | Health Technology |
SmartCells, Inc.
SmartCells, Inc. Medical SpecialtiesHealth Technology SmartCells, Inc. develops glucose-regulated smart insulin products for the treatment of diabetes. The company was founded by Todd C. Zion and James M. Herriman in 2003 and is headquartered in Beverly, MA. | Health Technology |